Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies

Geriatrics and Gerontology International

Volumn 16, Issue 2, 2016, Pages 155-166

  Tian, Simiao ^a   Xu, Yang ^a  

^a DALIAN UNIVERSITY   (China)

Author keywords

All cause mortality; Meta analysis; Prospective study; Sarcopenic obesity

Indexed keywords

ARM CIRCUMFERENCE; BODY FAT; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MORTALITY; MUSCLE STRENGTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SARCOPENIC OBESITY; SENSITIVITY ANALYSIS; UNITED STATES; WAIST CIRCUMFERENCE; COMPLICATION; META ANALYSIS; OBESITY; SARCOPENIA;

CAUSE OF DEATH; HUMANS; OBESITY; PROSPECTIVE STUDIES; SARCOPENIA;

EID: 84956805172     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12579     Document Type: Review

References (59)

1. Woodrow G. Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metab Care 2009; 12: 8-14.
2. Stenholm S, Harris TB, Rantanen T etal. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693-700.
3. Zoico E, Di Francesco V, Guralnik JM etal. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 2004; 28: 234-241.
4. Di Francesco V, Baggio E, Mastromauro M etal. Obesity and gastro-esophageal acid reflux: physiopathological mechanisms and role of gastric bariatric surgery. Obes Surg 2004; 14: 1095-1102.
5. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2007; 2: 183-189.
6. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008; 18: 388-395.
7. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012; 31: 583-601.
8. Baumgartner RN, Koehler KM, Gallagher D etal. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
9. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 2002; 50: 1802-1809.
10. Oliveira RJ, Bottaro M, Junior JT etal. Identification of sarcopenic obesity in postmenopausal women: a cutoff proposal. Braz J Med Biol Res 2011; 44: 1171-1176.
11. Kim TN, Yang SJ, Yoo HJ etal. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean Sarcopenic Obesity Study. Int J Obes 2009; 33: 885-892.
12. Batsis JA, Barre LK, Mackenzie TA etal. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: Dual-Energy X-Ray Absorptiometry data from the National Health and Nutrition Examination Survey 1994-2004. J Am Geriatr Soc 2013; 61: 974-980.
13. Kohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014; 45: 15-25.
14. Atkins JL, Whincup PH, Morris RW etal. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 2014; 62: 253-260.
15. Wannamethee SG, Shaper AG, Whincup PH etal. The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int J Cardiol 2014; 171: 49-55.
16. Scherzer R, Heymsfield SB, Lee D etal. Study of Fat Redistribution and Metabolic Change in HIV Infection FRAM; Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS 2011; 25: 1405-1414.
17. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007; 86: 1339-1346.
18. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 2014; 68: 1001-1007.
19. Cesari M, Pahor M, Lauretani F etal. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2009; 64: 377-384.
20. Stenholm S, Mehta NK, Elo IT etal. Obesity and muscle strength as long-term determinants of all-cause mortality-a 33-year follow-up of the Mini-Finland Health Examination Survey. Int J Obes (Lond) 2014; 38: 1126-1132.
21. Rantanen T, Harris T, Leveille SG etal. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000; 55: 168-173.
22. Al Snih S, Markides KS, Ray L, Ostir GV, Goodwin JS. Handgrip strength and mortality in older Mexican Americans. J Am Geriatr Soc 2002; 50: 1250-1256.
23. Hartung J, Knapp G, Sinha BK Statistical meta-analysis with applications, 2008.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials control. Clin Trials 1986; 7: 177-188.
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
28. Egger M, Smith GD, Schneider M, Minder CE. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
29. R Core Team. R: a language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria [Cited 2015.] Available from URL: www.R-project.org.
30. Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw 2010; 36: 1-48.
31. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6 (Suppl 2): 51S-209S.
32. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998; 68: 899-917.
33. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-161.
34. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
35. Cruz-Jentoft AJ, Baeyen JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
36. Oliveros E, Somers VK, Sochor O etal. The concept of normal weight obesity. Prog Cardiovasc Dis 2014; 56: 426-433.
37. Noori N, Kopple JD, Kovesdy CP etal. Mid-Arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 2258-2268.
38. Campbell AJ, Spears GFS, Brown JS, Busby WJ, Borrie MJ. Anthropometric measurements as predictors of mortality in a community population aged 70 years and over. Age Ageing 1990; 19: 131-135.
39. Muhlethaler R, Stuck AE, Minder CE, Frey BM. The prognostic significance of protein and energy malnutrition in geriatric patients. Age Ageing 1995; 24: 193-197.
40. Miller MD, Crotty M, Giles LC etal. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults? J Am Geriatr Soc 2002; 50: 1272-1277.
41. Landi F, Russo A, Liperoti R etal. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area ilSIRENTE study. Clin Nutr 2010; 29: 441-447.
42. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009; 13: 460-466.
43. Newman AB, Kupelian V, Visser M etal. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006; 61: 72-77.
44. Fujita Y, Nakumara Y, Hiraoka J etal. Physical-strength tests and mortality among visitors to health-promotion centers in Japan. J Clin Epidemiol 1995; 48: 1349-1359.
45. Visser M, Newman AB, Nevitt MC etal. Reexamining the sarcopenia hypothesis Muscle mass versus muscle strength Health, Aging, and Body Composition Study Research Group. Ann N Y Acad Sci 2000; 904: 456-461.
46. Katzmarzyk PT, Craig CL. Musculoskeletal fitness and risk of mortality. Med Sci Sports Exerc 2002; 34: 740-744.
47. Rantanen T, Volpato S, Ferrucci L etal. Handgrip strength and cause-specific and total mortality in older disable women: exploring the mechanism. J Am Geriatr Soc 2003; 51: 636-641.
48. Lim S, Kim JH, Yoon JW etal. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging KLoSHA. Diabetes Care 2010; 33: 1652-1654.
49. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000; 904: 437-448.
50. Baumgartner RN, Wayne SJ, Waters DL etal. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995-2004.
51. Aubertin-Leheudre M, Lord C, Goulet EDB etal. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity 2006; 14: 2277-2283.
52. Jarosz PA, Bellar A. Sarcopenic obesity: an emerging cause of frailty in older adults. Geriatr Nurs 2009; 30: 64-70.
53. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2013; 56: 270-278.
54. Lim KI, Yang SJ, Kim TN etal. The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean sarcopenic obesity study (KSOS). Clin Endocrinol 2010; 73: 588-594.
55. Prado CM, Lieffers JR, McCargar LJ etal. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-635.
56. Park SH, Park JH, Song PS etal. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens 2013; 7: 420-425.
57. Villareal DT, Banks M, Siener C, Sinacore DR, Klein S. Physical frailty and body composition in obese elderly men and women. Obes Res 2004; 12: 913-920.
58. Rolland Y, Lauwers-Cancers V, Cristini C etal. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) study. Am J Clin Nutr 2009; 89: 1895-1900.
59. Bussolotto M, Ceccon A, Sergi G etal. Assessment of body composition in elderly: accuracy of bioelectrical impedance analysis. Gerontology 1999; 45: 39-43.